Allergies News and Research

Latest Allergies News and Research

Understanding the rise in NTM infections

It is important to keep in mind that nontuberculous mycobacteria are environmental, and so unlike mycobacterial tuberculosis, generally this is not a person to person transmitted disease. The organisms are found universally in water and soil and so most people are exposed on a daily basis.

16 Aug 2017

FDA issues Emergency Use Authorization for multiplex Zika test

The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.

14 Aug 2017

Study provides new insight into development of immune cells

In contrast to what has been previously believed, development of blood stem cells to mast cells, a type of specialized immune cell, does not depend on a growth factor called stem cell factor.

10 Aug 2017

Increase in reported cases of Cyclospora infections compared to last year, CDC reports

The Centers for Disease Control and Prevention (CDC) has released a Health Alert Network (HAN) Health Advisory on 7th August 2017, Monday, in order to alert the health care facilities and the public health department on the increase in the reported cases of cyclosporiasis.

9 Aug 2017

‘Bureaucratic ninjas’ slice red-tape to battle health disparities

When a receptionist hands out a form to fill out at a doctor’s office, the questions are usually about medical issues: What’s the visit for? Are you allergic to anything? Up to date on vaccines?

7 Aug 2017

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

7 Aug 2017

Researchers hope to harness immune cells for better treatment of allergies, infections

By learning how a recently discovered immune cell works in the body, researchers hope to one day harness the cells to better treat allergies and infections, according to new Cornell University research.

4 Aug 2017

Protein that protects fetus during pregnancy could help treat atopic dermatitis

A protein which protects the fetus during pregnancy, HLA-G1, shows high potential for treating atopic dermatitis and other related diseases.

4 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.

3 Aug 2017

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

Common anti-allergy medicines could prove to be an effective treatment for potentially fatal blood clots in the legs, according to new research by the University of Birmingham.

2 Aug 2017

InDevR gets NIAID support for verification, validation studies on new potency test for influenza viruses

InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced support from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for verification and validation studies on a new potency test for influenza viruses with pandemic potential.

2 Aug 2017

Biomedical researcher wins $1.9 million federal grant to develop enhanced influenza vaccines

Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has renewed a four-year, $1.9 million federal grant to develop influenza vaccines that offer enhanced protection against a broad range of influenza virus strains.

31 Jul 2017

Immune system may wage a battle in Parkinson’s disease

A new study suggests that T cells, which help the body's immune system recognize friend from foe, may play an important role in Parkinson's disease (PD).

27 Jul 2017

New approach may improve translation of immunological research findings

Mouse models have advanced our understanding of immune function and disease in many ways but they have failed to account for the natural diversity in human immune responses.

27 Jul 2017

Dermatologists find increasing incidence of reaction to black henna tattoos

Dermatologists agree that incidences of black henna reactions are on the rise. Out of the 288 dermatologists who took part in the recent Skin Health Alliance 2017 Dermatologist Survey, 72% thought the incidence of patients with a reaction to black henna temporary tattoos is increasing year on year.

26 Jul 2017